Anbio Biotechnology Class A (NNNN) Stock Statistics & Valuation Metrics

Anbio Biotechnology Class A has a market cap or net worth of $7.35B. The enterprise value is ―.

Anbio Biotechnology Class A has 43,891,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anbio Biotechnology Class A’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.61%.

The current PE Ratio of Anbio Biotechnology Class A is 842.6. Anbio Biotechnology Class A’s PEG ratio is ―.

In the last 12 months, Anbio Biotechnology Class A had revenue of 8.19M and earned 2.37M in profits. Earnings per share was 0.06.

In the last 12 months, operating cash flow was 2.25M and capital expenditures 0.00, giving a free cash flow of 2.25M billion.

Anbio Biotechnology Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Anbio Biotechnology Class A upcoming earnings date is ―, ―.

Anbio Biotechnology Class A as a current ratio of 10.71, with Debt / Equity ratio of 0.00%

In the past 12 months, Anbio Biotechnology Class A has paid 0.00 in taxes.

Anbio Biotechnology Class A EV to EBITDA ratio is 90.49, with an EV/FCF ratio of 111.64.

Anbio Biotechnology Class A has $11.76M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$11.76M billion.

Gross margin is 71.90%, with operating margin of 24.38%, and net profit margin of 28.99%.

The average price target for Anbio Biotechnology Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―